Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
PaperCitations, authors & open-access status
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 382 citations, 2022 year and hybrid oa status.
382
Citations
2022
Year
hybrid
OA Status